More than 20,000 Australian patients a year will benefit from the listing of a capsule to relieve chronic breathlessness. Mayne Pharma’s Kapanol, a low-dose, sustained release […]
A national medication study is aiming to help thousands of Australians who struggle every day with shortness of breath.
Almost $5 million in grant funding – for three national palliative care projects – has been awarded to Flinders University by the Australian Government.
A drug which for decades has been widely used to treat pain related to cancer has no net clinical benefit.